Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Early Oral Switch for Uncomplicated Gram-negative Bacteraemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining an early oral switch strategy for uncomplicated gram-negative bacteremia is currently recruiting. The study is sponsored by Tan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tan Tock Seng Hospital | Conditions: Gram-negative Bacteraemia | Phase 4 | Status: RECRUITING